Targeted Therapy in Ovarian Cancer

por Willmott, Lyndsay J., Fruehauf, John P.
Publicado 2010

Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture

por Trapp, Valerie, Parmakhtiar, Basmina, Papazian, Vartan, Willmott, Lyndsay, Fruehauf, John P.
Publicado 2010

A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer

por Zhuang, Eric, Uchio, Edward, Lilly, Michael, Zi, Xiaolin, Fruehauf, John P.
Publicado 2021

Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma

por Eroglu, Zeynep, Kong, Kevin M., Jakowatz, James G., Samlowski, Wolfram, Fruehauf, John P.
Publicado 2011

Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma

por Fruehauf, John P., El-Masry, Monica, Osann, Katherine, Parmakhtiar, Basmina, Yamamoto, Maki, Jakowatz, James G.
Publicado 2018

Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer

por Tran Cao, Hop S., Bouvet, Michael, Kaushal, Sharmeela, Keleman, Alex, Romney, Eric, Kim, Ginna, Fruehauf, John, Imagawa, David K., Hoffman, Robert M., Katz, Matthew H.G.
Publicado 2010